Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

JNJ-40346527

Generic Name: JNJ-40346527

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₃₅N_₅O_₂

CAS Number: 1142363-52-7

Unique Ingredient Identifier: 3NU609VYNF

Overview

JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.

Background

JNJ-40346527 has been used in trials studying the treatment of Health and Arthritis, Rheumatoid.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

MIcroglial Colony Stimulating Factor-1 Receptor (CSF1R) in Alzheimer's Disease

Phase 1

Terminated

Posted: 2019/10/09

Sponsor:University of Oxford

ID:NCT04121208

Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer

Phase 1

Completed

Posted: 2017/06/06

Sponsor:M.D. Anderson Cancer...

ID:NCT03177460

A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy

Phase 2

Completed

Posted: 2012/05/14

Sponsor:Janssen Research & D...

ID:NCT01597739

A Single and Multiple Dose Study to Explore the Safety Of JNJ-40346527 In Healthy Volunteers

Phase 1

Completed

Posted: 2010/01/22

Sponsor:Johnson & Johnson Ph...

ID:NCT01054014

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy